Share
The Impact of Off-Label, Compassionate, and Unlicensed use on Health Care Laws in Preselected Countries
Vanessa PlatÉ (Author)
·
Ibidem Press
· Paperback
The Impact of Off-Label, Compassionate, and Unlicensed use on Health Care Laws in Preselected Countries - Vanessa PlatÉ
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My Wishlists
Origin: U.S.A.
(Import costs included in the price)
It will be shipped from our warehouse between
Friday, June 14 and
Tuesday, July 02.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.
Synopsis "The Impact of Off-Label, Compassionate, and Unlicensed use on Health Care Laws in Preselected Countries"
In times of situational therapeutic impasse, health care professionals (HCPs) are under pressure to conduct off-label, unlicensed and compassionate drug use―generally summarized under the term non-licensed drug use (NDU). Liability, contractual and penal risks pose a problem when treating a patient in a non-licensed way. There is a knowledge gap about institutional and governmental methods to resolve these problems. Different countries have developed strategies to manage NDU. Vanessa Platé gives a comprehensive overview of practices Canada, the U.S., the U.K., Japan, France, Germany, Switzerland, Austria, and the transnational E.U. A must-read for everyone interested in the discussion on how to administer the best treatment, especially regarding early access to yet unapproved treatments.
